Zota Health Care Ltd

Zota Health Care Ltd demonstrates concerning trends in financial performance and growth. While sales growth has been robust, the company struggles with profitability. The compounded profit growth is significantly negative. Declining OPM and net profit margins indicate operational inefficiencies affecting the bottom line.

| Metric | 2020-2022 | 2023 | 2024 | 2025 | |---|---|---|---| |Compounded Sales Growth (%) | 31% | 31% | 31% | 62% | |Compounded Profit Growth (%) | - | - | - | -293% |

Zota Health Care has experienced fluctuating sales and profit figures. Sales have generally increased, but profitability has declined, particularly in recent quarters. This inconsistency raises concerns about the sustainability of the company's earnings.The decline in profitability despite sales growth indicates potential issues with cost management or pricing strategies.

Zota Health Care Ltd exhibits poor capital efficiency and returns. The current and historical ROCE values are negative, indicating that the company is not effectively utilizing its capital. ROE is also negative, suggesting that shareholder funds are not generating satisfactory returns.

| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | |---|---|---|---|---| | ROCE (%) | -2% | 15% | -2% | -7% | -17% | | ROE (%) | - | - | - | - | -36% |

The Cash Conversion Cycle is notably high, reflecting inefficiencies in working capital management. This indicates that the company is taking longer to convert its investments in inventory and receivables into cash, potentially straining its liquidity and increasing its financing needs.

Zota Health Care Ltd's financial health and prudence are weak. The company's borrowings have increased significantly over the years, leading to a higher debt/equity ratio. Interest coverage is declining, indicating difficulties in covering interest obligations comfortably.

| Metric | 2022 | 2023 | 2024 | 2025 | |---|---|---|---| | Borrowings (₹ Cr) | 15 | 45 | 95 | 140 | | Interest (₹ Cr) | 0 | 3 | 5 | 11 |

The increasing debt poses a significant risk, potentially leading to financial distress if profitability does not improve.

Zota Health Care Ltd shows an average shareholding and ownership structure. The promoter holding has decreased over the recent quarters, indicating a potential lack of confidence or strategic shift. Institutional holding, while present, is relatively low, suggesting limited interest from institutional investors.

| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Apr 2025 | |---|---|---|---| | Promoter Holding (%) | 68.12% | 66.15% | 59.72% | 58.11% |

This decline in promoter holding could signal a shift in the company's strategic direction or a decrease in confidence among the promoters. The relatively low institutional holding indicates that the company may not be as attractive to institutional investors, potentially affecting its stock liquidity and valuation.

Zota Health Care Ltd shows significant volatility in its quarterly results. The operating profit margin (OPM) fluctuates from positive to negative values, indicating instability in operational efficiency.

| Quarter | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | |---|---|---|---|---| | OPM (%) | -3% | -2% | -1% | -8% | 3% |

This variability indicates that Zota Health Care must proactively manage its diverse segments to ensure consistent overall financial health.

Given the increasing borrowings and interest expenses, Zota Health Care Ltd is likely exposed to interest rate risk. Fluctuations in interest rates could impact the company's profitability.

The increase in 'Expenses' indicate potential regulatory compliance cost trends.